News
As major insurers reduce Medicare Advantage benefits and exit markets, retirees face higher costs and limited options.
Private equity firms have been under pressure to return money to their investors as a dealmaking slump drags on for a third year. Distributions as a percentage of fund values tumbled to 7% as of the ...
New Customers, Solid Prescription Trend, and Growing Specialties Support Cardinal's Long-Term Growth
Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...
1d
TipRanks on MSNCVS vs. UNH: Which Healthcare Stock is a Better Buy After Q2 Earnings?
CVS Health ($CVS) and UnitedHealth Group ($UNH), two of the largest players in the healthcare sector, recently reported their ...
Vendor sprawl isn’t a new problem. But for today’s healthcare CIO, it’s become a central concern—one with broad implications for performance, security, and long-term strategy. As CIOs take on expanded ...
1d
The Mirror US on MSNTarget, CVS and Kroger launch ban campaign — shoppers will see new charges on receipts
The "Break Up with Single-Use Bags" campaign in California aims to prohibit shoppers from using disposable plastic bags ...
Watchtower Advisors LP has invested $17.62 million in CVS Health Corporation, securing 260,000 shares. This significant ...
As healthcare continues its push toward outpatient, value-based care, hospitals and health systems are staking claims in a growing — and increasingly critical — sector: urgent care. Once viewed as an ...
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.
Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results